Description
Glutathione IV 200MG / ML – 30ml
Clinical Test Expectation – Human Subjects: Reduces oxidative stress, may improve psoriasis. Reduces cell damage in alcoholic and nonalcoholic fatty liver disease. Improves insulin resistance in older individuals. Increases mobility for people with peripheral artery disease. Reduces symptoms of Parkinson’s disease. May help fight against autoimmune disease. May reduce oxidative damage in children with autism. May reduce the impact of uncontrolled diabetes. May reduce respiratory disease symptoms
WE OFFER NO DOSING PROTOCOLS ON THIS ITEM, GLUTATHIONE IV, AS IT IS STRICTLY TO BE ADMINISTERED BY REGISTERED NURSE OR DOCTOR. RESEARCH PEPTIDES SOUTH AFRICA IS NOT RESPONSIBLE FOR ANY ANAPHYLACTIC OR OTHERWISE LIFE THREATENING CONSEQUENCES AS A RESULT OF USE OF THESE PRODUCTS
Reviews
There are no reviews yet.